Difference between revisions of "FDA stem cells"
Jump to navigation
Jump to search
(Created page with "'''FDA stem cell''' court cases total 215, of which 178 are federal court decisions concerning the FDA and stem cells. Generally the FDA attempts to block and impede...") |
(extracellular vesicle) |
||
| Line 1: | Line 1: | ||
| − | '''FDA stem cell''' court cases total 215, of which 178 are federal court decisions concerning the [[FDA]] and [[stem cells]]. Generally the FDA attempts to block and impede the use of adult stems cells as much as the FDA possibly can, and often beyond what [[Congress]] has authorized the FDA to do. | + | '''FDA stem cell''' court cases total 215, of which 178 are federal court decisions concerning the [[FDA]] and [[stem cells]]. Of these, the FDA was a party in |
| + | |||
| + | Generally the FDA attempts to block and impede the use of adult stems cells as much as the FDA possibly can, and often beyond what [[Congress]] has authorized the FDA to do. | ||
| + | |||
| + | == Analogous therapies == | ||
| + | |||
| + | The [[Fifth Circuit]] found that "extracellular vesicle ("EV") [is a] product similar to stem cell therapy." ''Direct Biologics, L.L.C. v. McQueen'', 63 F.4th 1015, 1017 (5th Cir. 2023) (deciding a [[trade secret]]-related issue. | ||
[[category:stem cells]] | [[category:stem cells]] | ||
Revision as of 02:45, July 13, 2023
FDA stem cell court cases total 215, of which 178 are federal court decisions concerning the FDA and stem cells. Of these, the FDA was a party in
Generally the FDA attempts to block and impede the use of adult stems cells as much as the FDA possibly can, and often beyond what Congress has authorized the FDA to do.
Analogous therapies
The Fifth Circuit found that "extracellular vesicle ("EV") [is a] product similar to stem cell therapy." Direct Biologics, L.L.C. v. McQueen, 63 F.4th 1015, 1017 (5th Cir. 2023) (deciding a trade secret-related issue.